Literature DB >> 16843256

Improving influenza vaccination rates for children through year-round scheduling.

Ian M Paul1, Sara B Eleoff, Michele L Shaffer, Ryan M Bucher, Kathleen M Moyer, Maryellen E Gusic.   

Abstract

OBJECTIVE: Barriers to influenza vaccination negatively impact immunization rates contributing to the morbidity and mortality from influenza. This study sought to determine if 1) the availability of year-round scheduling of annual autumn/winter influenza vaccination was associated with improved immunization rates for 2 high-risk populations of children and 2) this system was associated with early season vaccine administration.
METHODS: A retrospective cohort analysis was utilized to compare immunization rates during the 2003-2004 and 2004-2005 seasons. Billing records were used to determine eligible patients and vaccine receipt. A single, pediatric practice was studied, and two groups of patients were analyzed: 1) infants aged 6-23 months and 2) children < 21 years old with asthma. As opposed to Year 1, in Year 2 appointments in "flu clinics" for the following autumn became available 7 months prior to when vaccine became available. Patients and providers could therefore schedule an immunization appointment throughout the year.
RESULTS: In Year 1, 552/1365 (40.4%) infants received at least 1 dose of influenza vaccine compared to 940/1265 (74.3%) in Year 2 (p < 0.001). For patients with asthma, 309/1332 (23.2%) received at least 1 dose of vaccine in Year 1 compared with 522/1489 (35.1%) in Year 2 (p <0.001). Both groups also achieved higher immunization rates between September and November in Year 2 (p < 0.001).
CONCLUSIONS: Year-round scheduling of influenza vaccination was associated with improved immunization rates in two high-risk populations, and may remove the barrier of scheduling difficulty, allow for a consistent year-round message from providers, and improve timing of vaccine administration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16843256     DOI: 10.1016/j.ambp.2006.04.006

Source DB:  PubMed          Journal:  Ambul Pediatr        ISSN: 1530-1567


  6 in total

1.  Assessment of parental report for 2009-2010 seasonal and monovalent H1N1 influenza vaccines among children in the emergency department or hospital.

Authors:  Katherine A Poehling; Lauren Vannoy; Laney S Light; Cynthia K Suerken; Beverly M Snively; Alejandra Guitierrez; Timothy R Peters
Journal:  Acad Pediatr       Date:  2011-10-26       Impact factor: 3.107

2.  Practice and child characteristics associated with influenza vaccine uptake in young children.

Authors:  Katherine A Poehling; Gerry Fairbrother; Yuwei Zhu; Stephanie Donauer; Sandra Ambrose; Kathryn M Edwards; Mary Allen Staat; Mila M Prill; Lyn Finelli; Norma J Allred; Barbara Bardenheier; Peter G Szilagyi
Journal:  Pediatrics       Date:  2010-09-06       Impact factor: 7.124

3.  The impact of missed opportunities on seasonal influenza vaccination coverage for healthy young children.

Authors:  Norma J Allred; Katherine A Poehling; Peter G Szilagyi; Fan Zhang; Kathryn M Edwards; Mary Allen Staat; Stephanie Donauer; Mila M Prill; Gerry Fairbrother
Journal:  J Public Health Manag Pract       Date:  2011 Nov-Dec

4.  Cluster randomized trial of a toolkit and early vaccine delivery to improve childhood influenza vaccination rates in primary care.

Authors:  Richard K Zimmerman; Mary Patricia Nowalk; Chyongchiou Jeng Lin; Kristin Hannibal; Krissy K Moehling; Hsin-Hui Huang; Annamore Matambanadzo; Judith Troy; Norma J Allred; Greg Gallik; Evelyn C Reis
Journal:  Vaccine       Date:  2014-04-29       Impact factor: 3.641

5.  Trends in compliance with two-dose influenza vaccine recommendations among children aged 6 months through 8 years.

Authors:  Laura J Pabst; Sandra S Chaves; Cindy Weinbaum
Journal:  Vaccine       Date:  2013-05-15       Impact factor: 3.641

6.  Factors associated with in-office influenza vaccination by U.S. pediatric providers.

Authors:  Chyongchiou Jeng Lin; Mary Patricia Nowalk; Seth L Toback; Christopher S Ambrose
Journal:  BMC Pediatr       Date:  2013-11-06       Impact factor: 2.125

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.